Global Antibiotic R&D Partnership (GARDP)
Nathalie Khavessian is an accomplished professional with extensive experience in clinical development and project management. Currently serving as R&D Partnerships and Project Senior Manager at the Global Antibiotic R&D Partnership (GARDP) since July 2018, Nathalie previously held roles including Clinical Development Project Manager at GeNeuro SA, where key responsibilities involved managing a Phase IIb clinical trial in Multiple Sclerosis. Nathalie's background also includes work as a Project Officer at International Social Service, and various project management positions at Covance CLS, where notable achievements include engagement with pharmaceutical clients and mentoring new staff. Academically, Nathalie holds a Master's degree in Clinical Research and Drug Development from the University of Geneva, along with several project management certifications and a diploma in hotel management.
This person is not in the org chart
This person is not in any offices
Global Antibiotic R&D Partnership (GARDP)
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, India, Japan, and South Africa for antibiotic development and access. Its work is made possible by essential funding from donors and collaboration with over 100 R&D and access partners in over 20 countries. GARDP was created by the World Health Organization and the Drugs for Neglected Diseases initiative (DNDi) in 2016 and legally registered as the GARDP Foundation in Geneva, Switzerland in 2018. www.gardp.org